152 related articles for article (PubMed ID: 35781489)
1. Identification of ELK1 interacting peptide segments in the androgen receptor.
Soave C; Ducker C; Kim S; Strahl T; Rosati R; Huang Y; Shaw PE; Ratnam M
Biochem J; 2022 Jul; 479(14):1519-1531. PubMed ID: 35781489
[TBL] [Abstract][Full Text] [Related]
2. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain.
Soave C; Ducker C; Islam N; Kim S; Yurgelevic S; Nicely NI; Pardy L; Huang Y; Shaw PE; Auner G; Dickson A; Ratnam M
Mol Pharmacol; 2023 Apr; 103(4):211-220. PubMed ID: 36720643
[TBL] [Abstract][Full Text] [Related]
3. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.
Rosati R; Patki M; Chari V; Dakshnamurthy S; McFall T; Saxton J; Kidder BL; Shaw PE; Ratnam M
J Biol Chem; 2016 Dec; 291(50):25983-25998. PubMed ID: 27793987
[TBL] [Abstract][Full Text] [Related]
4. Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.
Rosati R; Polin L; Ducker C; Li J; Bao X; Selvakumar D; Kim S; Xhabija B; Larsen M; McFall T; Huang Y; Kidder BL; Fribley A; Saxton J; Kakuta H; Shaw P; Ratnam M
Clin Cancer Res; 2018 Dec; 24(24):6509-6522. PubMed ID: 30185422
[TBL] [Abstract][Full Text] [Related]
5. The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells.
Patki M; Chari V; Sivakumaran S; Gonit M; Trumbly R; Ratnam M
J Biol Chem; 2013 Apr; 288(16):11047-65. PubMed ID: 23426362
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
[TBL] [Abstract][Full Text] [Related]
7. The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.
Pardy L; Rosati R; Soave C; Huang Y; Kim S; Ratnam M
Prostate; 2020 Feb; 80(2):198-208. PubMed ID: 31794091
[TBL] [Abstract][Full Text] [Related]
8. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
Weber H; Ruoff R; Garabedian MJ
PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
[TBL] [Abstract][Full Text] [Related]
9. Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.
Kawahara T; Aljarah AK; Shareef HK; Inoue S; Ide H; Patterson JD; Kashiwagi E; Han B; Li Y; Zheng Y; Miyamoto H
Prostate; 2016 Jun; 76(8):744-56. PubMed ID: 26864615
[TBL] [Abstract][Full Text] [Related]
10. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
11. ELK1/KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism.
Yang B; Wang H; Xiao J; Chen W; Chen W
J Obstet Gynaecol Res; 2023 Aug; 49(8):2175-2184. PubMed ID: 37339943
[TBL] [Abstract][Full Text] [Related]
12. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
13. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.
Sen A; De Castro I; Defranco DB; Deng FM; Melamed J; Kapur P; Raj GV; Rossi R; Hammes SR
J Clin Invest; 2012 Jul; 122(7):2469-81. PubMed ID: 22684108
[TBL] [Abstract][Full Text] [Related]
14. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
[TBL] [Abstract][Full Text] [Related]
15. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
Minamiguchi K; Kawada M; Ohba S; Takamoto K; Ishizuka M
Mol Cell Endocrinol; 2004 Feb; 214(1-2):175-87. PubMed ID: 15062556
[TBL] [Abstract][Full Text] [Related]
17. Allosteric conversation in the androgen receptor ligand-binding domain surfaces.
Grosdidier S; Carbó LR; Buzón V; Brooke G; Nguyen P; Baxter JD; Bevan C; Webb P; Estébanez-Perpiñá E; Fernández-Recio J
Mol Endocrinol; 2012 Jul; 26(7):1078-90. PubMed ID: 22653923
[TBL] [Abstract][Full Text] [Related]
18. A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin.
Need EF; Scher HI; Peters AA; Moore NL; Cheong A; Ryan CJ; Wittert GA; Marshall VR; Tilley WD; Buchanan G
Endocrinology; 2009 Jun; 150(6):2674-82. PubMed ID: 19282387
[TBL] [Abstract][Full Text] [Related]
19. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
Zhou ZX; He B; Hall SH; Wilson EM; French FS
Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor interacts with a novel MYST protein, HBO1.
Sharma M; Zarnegar M; Li X; Lim B; Sun Z
J Biol Chem; 2000 Nov; 275(45):35200-8. PubMed ID: 10930412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]